EMCURE:NSE
Emcure Pharmaceuticals Ltd
2 332,30 INR
arrow_downward
-0,30%(-7,10) 1D
18-ноя., 15:27:16 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EMCURE...
Open
2 354,90 INR
High
2 402,00 INR
Low
2 326,00 INR
Mkt. cap
442,46 млд
Avg. vol.
231,90 миң
Volume
253,03 миң
Dividend
0,15%
Quarterly dividend
0,90 INR
Ex-dividend date
2026-ж., 4-сен.
P/E ratio
48,96
52-wk high
2 429,90 INR
52-wk low
1 312,30 INR
EPS
47,64 INR
No. of employees
7 миң
Open
2 354,90 INR
High
2 402,00 INR
Low
2 326,00 INR
Mkt. cap
442,46 млд
Avg. vol.
231,90 миң
Volume
253,03 миң
Dividend
0,15%
Quarterly dividend
0,90 INR
Ex-dividend date
2026-ж., 4-сен.
P/E ratio
48,96
52-wk high
2 429,90 INR
52-wk low
1 312,30 INR
EPS
47,64 INR
No. of employees
7 миң
News stories
From web sources and news partners
MarketWatch
·
1 саат мурун
Stock Market Today: Dow, S&P 500 and Nasdaq set to climb as Nvidia shares rise after boosting guidance; Anthropic expected to price IPO: live updates
MarketWatch
·
1 саат мурун
The S&P 500 just broke a crucial support level. Here’s what history shows may happen now.
Investing.com
·
2 саат мурун
The S&P 500 Is at a Crossroads as Nvidia Fails to Impress
www.tokenpost.com
·
41 мүнөт мурун
Nasdaq Gains 0.91% as S&P 500 Futures and Dow Also Advance
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees6,91 миң
Founded1981-ж., 16-апр.
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteemcure.com